Is Genpharmasec Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Genpharmasec Ltd (531592.BO) is currently classified as HALAL as of January 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Genpharmasec Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Genpharmasec Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Genpharmasec Ltd?

Muslim investors may consider investing in Genpharmasec Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Genpharmasec Ltd classified as HALAL?

Musaffa determines the Shariah status of Genpharmasec Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Genpharmasec Ltd updated?

The Shariah compliance status of Genpharmasec Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Genpharmasec Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Genpharmasec Ltd?

You can check the latest Shariah compliance status of Genpharmasec Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Genpharmasec Ltd 531592.BO

₹1.16 ₹0.04 (3.57%) 1D

Last Updated: May 15, 12:00 AM·BSE

531592.BO Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: January 27, 2026

Report Source: 2026 2nd Quarter Report

Genpharmasec Ltd. Stock Analysis 531592.BO

India Industrials Nano Cap Report: Q2, 2026

Genpharmasec Ltd. engages in pharmaceutical activities, services, and trading in equity shares. The Company’s segments include Pharmaceuticals, Trading in Securities, and Laboratory Testing. The Trading in Securities segment invests in the secondary securities market. The firm holds rights to the distribution of equipment, such as i-STAT Analyzers and its Cartridges, manufactured by Abbott Point of Care, USA, all over India. The i-STAT Analyzer is a blood analyzer used in Intensive Care Units (ICUs) of hospitals and provides test results in approximately 10 minutes. The Company’s wholly owned subsidiary includes M/s. Clinigenome India Private Limited.

Key Statistics of Genpharmasec Ltd (531592.BO)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹1.10₹1.16

Today's Open

₹1.12

Volume

213.05K

P/E Ratio (TTM)

53.70

52 Week Range

₹0.75₹2.38

Market Cap

626.66M

Avg. Volume

381.53K

Dividend Yield

Financial Metrics & Statements of Genpharmasec Ltd (531592.BO)

Community-Curated Collections with Genpharmasec Ltd (531592.BO) ( With 531592.BO )

View All

Community-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.

AUG 2024 HOLDINGS

By Sabira Salih

9 Followers

+46 more

FAQ's for Genpharmasec Ltd (531592.BO)

According to Musaffa’s Shariah screening methodology, Genpharmasec Ltd (531592.BO) is currently classified as HALAL as of January 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.